PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme
14 januari 2019 uppdaterad av: University Hospitals, Leicester
Prevention Strategies for Adolescents at Risk of Diabetes - A Randomised Controlled Trial of an Interactive Family-based Lifestyle Programme
To investigate whether the interactive family based lifestyle programme leads to behaviour change at 6 months with the primary outcome being increased levels of moderate to vigorous physical activity (MVPA).
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Child)
- An increase in objectively measured total amount of physical activity
- An increase in the proportion meeting MVPA guidelines (measured objectively)
- Reduction in time spent sedentary (measured objectively and self-reported)
- Change in self-reported physical activity
- Reduction in measures of adiposity (body mass index percentile, per cent body fat)
- Improvement in psychological factors that may mediate physical activity participation (self-efficacy, motivation, attitudes, social support and enjoyment of physical activity; and physical self-perceptions)
- Change in healthy food provision and parenting practices for healthy food
- Improvement in diet composition.
- Improvement in knowledge of physical activity and nutrition.
- Improvement in cardio-metabolic variables (blood pressure, glucose, HbA1c, cholesterol)
The Investigators will also include qualitative data collected from:
- Evaluation forms following each intervention workshop session which will be completed by the Parent/guardian, child and facilitator
- Feedback from focus groups to be held following completion of the total intervention i.e. 8 sessions
To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Parent(s)/guardian(s))
- An increase in objectively measured total volume of physical activity
- An increase in the proportion meeting MVPA guidelines (measured objectively)
- Reduction in time spent sedentary (measured objectively and self-reported)
- Change in self-reported physical activity
- Reduction in measures of adiposity (body mass index percentile, per cent body fat)
- Change in healthy food provision and parenting practices for healthy food
- Improvement in diet composition.
- Improvement in knowledge of physical activity and nutrition.
Studietyp
Interventionell
Inskrivning (Faktisk)
318
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Leicester, Storbritannien, LE4 5pW
- University Hospitals of Leicester
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
12 år till 14 år (Barn)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
Parents/guardians will answer questions in the eligibility questionnaire about their child and family health history. Participants will be invited to participate if they are 12-14 years old inclusive (12 years 0 days to 14 years 354 days old) and are identified as having the following risk factors for development of Type 2 Diabetes (which will be identified from the eligibility questionnaire):
BMI > 95th percentile for age and gender OR
BMI > 85th percentile PLUS one other from the following list:
- Family history of Diabetes (first degree relative).
- Non-white ethnicity.
- Watching TV/play computer games for more than 2 hours a day (self-report).
- Sugar intake more than 1.5 cans (or 532 ml) of fizzy pop/fruit juice per day (self-report).
Exclusion Criteria:
Young people will not be eligible for participation in the study if they are outside the age range of interest (<11 years and 364 days or >14 years and 1 day), have an existing diagnosis of Type 1 or Type 2 Diabetes, < 85th percentile. Young people will also be excluded if they themselves do not provide written assent or their parent/guardian does not provide written consent.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Control
The control participants will not receive the educational intervention but will be provided with a detailed advice leaflet for themselves and their parents/guardians.
|
|
|
Övrig: Intervention
The educational intervention participants will receive the eight 90 minute sessions of an interactive family based lifestyle programme.
|
Participants will attend eight 90 minute sessions of an interactive lifestyle programme along with their parent(s)/guardian(s).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The primary endpoint is to detect a change in objectively measured MVPA of 10 minutes per day within the intervention group at 6 months.
Tidsram: 6 months post baseline
|
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
|
6 months post baseline
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
An increase in total volume of physical activity
Tidsram: 3 and 6 months
|
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
|
3 and 6 months
|
|
An increase in the proportion meeting MVPA guidelines
Tidsram: 3 and 6 months
|
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
|
3 and 6 months
|
|
Reduction in time spent sedentary
Tidsram: 3 and 6 months
|
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
|
3 and 6 months
|
|
Change in physical activity levels
Tidsram: 3 and 6 months
|
Self reported - questionnaire
|
3 and 6 months
|
|
Reduction in Body mass index percentile (BMI)
Tidsram: 3 and 6 months
|
Body mass will be measured to the nearest 0.1kg and height will be measured to the nearest 0.1 cm using a clinically approved bioelectrical impedance scale and a portable stadiometer, respectively.
BMI will be calculated as weight/height2 and will be converted to a BMI percentile based on WHO growth charts
|
3 and 6 months
|
|
Change in healthy food provision and parenting practices for healthy food
Tidsram: 3 and 6 months
|
As parents are active participants in the intervention The Investigators will also query their knowledge and attitudes towards healthy eating and physical activity.
|
3 and 6 months
|
|
Improvement in diet composition
Tidsram: 3 and 6 months
|
The Investigators will query the nutrition habits of participants to investigate any changes in the behaviours targeted in the workshops.
A food frequency questionnaire (FFQ) taken from the ISCOLE study that was adapted from the HBSC Study will be used to query the consumption of 23 food categories in a "usual" week.
The Investigators will also query breakfast consumption for weekdays and weekends.
The Investigators have also created ad hoc questions on other intervention targets of snacking behaviours, fruit and vegetable intake and fizzy drink consumption.
This ad hoc method has been used in other international multi-site studies.
|
3 and 6 months
|
|
Improvement in knowledge of physical activity and nutrition
Tidsram: 3 and 6 months
|
The physical activity questionnaire for adolescents (PAQ-A) [62] will be used to assess the Types and context of physical activity in order to investigate changes in the Types of sports/exercise/activities the participating child may participate in (information which is not available from the accelerometer or the majority of other validated self-report questionnaires).
This questionnaire requests responses for the last 7 days by asking participants to check a list of activities for frequency of participation.
This questionnaire has received support from an expert panel and has also high validity against objective measures and moderate reliability.
|
3 and 6 months
|
|
Improvement in HbA1c
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) - HbA1c
|
3 and 6 months
|
|
Improvement in Triglycerides
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) - Triglycerides
|
3 and 6 months
|
|
Improvement in Glucose
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) - Glucose
|
3 and 6 months
|
|
Improvement in HDL-C
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) HDL-C
|
3 and 6 months
|
|
Improvement in Total Cholesterol
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) -Total cholesterol will be measured using a point-of-care testing (POCT) and LDL-C will be calculated.
|
3 and 6 months
|
|
Improvement in cardio-metabolic variables
Tidsram: 3 and 6 months
|
Biochemical measures (Child only) - Capillary blood samples will be taken from each child using the finger prick method.
The CardioChek® system will be used as the POCT method.
The CardioChek® system is a portable hand held device that requires between 15 to 40 µL capillary sample from a finger-stick for each test.
The CardioChek® system is certified by the Cholesterol Reference Method Laboratory Network (CRMLN) and National Cholesterol Education Program (NCEP), is FDA-cleared, CE-marked, internationally registered, and is CLIA-waived by the Centers for Medicare & Medicaid Services, USA.
|
3 and 6 months
|
|
Blood Pressure (Child)
Tidsram: 3 and 6 months
|
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes.
Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.
|
3 and 6 months
|
|
Blood Pressure (Parent(s)/guardian(s))
Tidsram: 3 and 6 months
|
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes.
Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.
|
3 and 6 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Melanie J Davies, MD, University Hospitals, Leicester
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 juli 2016
Primärt slutförande (Faktisk)
1 mars 2017
Avslutad studie (Faktisk)
1 oktober 2017
Studieregistreringsdatum
Först inskickad
5 maj 2016
Först inskickad som uppfyllde QC-kriterierna
22 juli 2016
Första postat (Uppskatta)
27 juli 2016
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
16 januari 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
14 januari 2019
Senast verifierad
1 januari 2019
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 65436
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Ja
IPD-planbeskrivning
Non identifiable participant data will be only be shared with the study collaborators.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Fetma
-
SanionaAvslutadHypothalamic Injury-induced Obesity (HIO)Danmark